These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1175123

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.
    Case DC, Lee DJ, Clarkson BD.
    Am J Med; 1977 Dec; 63(6):897-903. PubMed ID: 605911
    [No Abstract] [Full Text] [Related]

  • 7. Bone healing in multiple myeloma with melphalan chemotherapy.
    Rodriguez LH, Finkelstein JB, Shullenberger CC, Alexanian R.
    Ann Intern Med; 1972 Apr; 76(4):551-6. PubMed ID: 4640313
    [No Abstract] [Full Text] [Related]

  • 8. Prognosis of myelomatosis on treatment with prednisone and cytostatics.
    Hansen OP, Jessen B, Videbaek A.
    Scand J Haematol; 1973 Apr; 10(4):282-90. PubMed ID: 4764610
    [No Abstract] [Full Text] [Related]

  • 9. Correlation of abnormal immunoglobulin with clinical features of myeloma.
    Arch Intern Med; 1975 Jan; 135(1):46-52. PubMed ID: 1111470
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients.
    Belch A, Shelley W, Bergsagel D, Wilson K, Klimo P, White D, Willan A.
    Br J Cancer; 1988 Jan; 57(1):94-9. PubMed ID: 3279997
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma.
    Cavo M, Baccarani M, Gobbi M, Lipizer A, Tura S.
    Br J Haematol; 1983 Dec; 55(4):683-90. PubMed ID: 6671088
    [Abstract] [Full Text] [Related]

  • 15. A prognostic index for multiple myeloma.
    Grignani G, Gobbi PG, Formisano R, Pieresca C, Ucci G, Brugnatelli S, Riccardi A, Ascari E.
    Br J Cancer; 1996 May; 73(9):1101-7. PubMed ID: 8624271
    [Abstract] [Full Text] [Related]

  • 16. Treatment of multiple myeloma.
    Waldenström J.
    Br J Haematol; 1968 Sep; 15(3):217-20. PubMed ID: 5681477
    [No Abstract] [Full Text] [Related]

  • 17. Combination therapy for multiple myeloma.
    Alexanian R, Salmon S, Bonnet J, Gehan E, Haut A, Weick J.
    Cancer; 1977 Dec; 40(6):2765-71. PubMed ID: 589554
    [Abstract] [Full Text] [Related]

  • 18. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP, Jessen B, Videbaek A.
    Ugeskr Laeger; 1973 Jun 04; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.